Business Context and Reporting Period
This Form 8-K Current Report was filed by Enochian Biosciences, Inc. (not Lunai Bioworks Inc.) on February 11, 2019. The registrant is a Delaware corporation with principal executive offices in Los Angeles, CA. The filing serves as a Regulation FD disclosure to make an Investor Presentation available to the public.
Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses solely on the dissemination of an attached presentation and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is procedural, intended to satisfy disclosure obligations regarding the release of an Investor Presentation (Exhibit 99.1).
Guidance, Outlook, and Risks
- Management Commentary: The Company has made an Investor Presentation available as Exhibit 99.1.
- Forward-Looking Statements: The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is not deemed filed for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that Section.
- Update Obligation: The Company undertakes no duty or obligation to update or revise the information included in this Report or the Exhibit.
Key Facts for Investor Verification
- Verify the actual content of the Investor Presentation (Exhibit 99.1) for any specific business updates, as the 8-K text itself contains no operational details.
- Confirm the registrant name is Enochian Biosciences, Inc., noting the discrepancy with the requested company name "Lunai Bioworks Inc."
- Note that the information provided is not subject to the liabilities of Section 18 of the Exchange Act and the Company has disclaimed any obligation to update it.